Kyongbo Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kyongbo Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
Ctc Bio, Incorporation.
sales of 138.40 billion Korean Won [US$121.65 million]
of which 74%
was Animal Medication),
(179.32 billion Korean Won [US$157.62 million]
of which 93%
was Medicine), and
(158.72 billion Korean Won [US$139.52 million]
of which 100%
was manufacture and distribution of pharmace).
During the year ended December of 2018, sales at
Kyongbo Pharmaceutical Co Ltd were 201.34 billion Korean Won (US$176.98 million).
increase of 5.1%
versus 2017, when the company's sales were 191.66 billion Korean Won.
This was the fifth consecutive year of sales increases at Kyongbo Pharmaceutical Co Ltd
(and since 2013, sales have increased a total of 24%).